COVID-19 vaccination in Spain
From Wikipedia, the free encyclopedia
Asturian residential home worker ready to get the COVID-19 vaccine | |
| Date | December 27, 2020 – present |
|---|---|
| Duration | 4 years, 7 months and 6 days |
| Location | Spain |
| Cause | COVID-19 pandemic in Spain |
| Target | Adult population (age 12+) and children (age 5+) |
| Organised by | Ministry of Health |
| Participants | 40.911.451 people |
| Outcome | 86,2% partially vaccinated (1 of 2 doses) 80,7% fully vaccinated[1] (46,2% with booster dose) |
| Website | Gobierno de España |
| Updated in January 31, 2022 | |
COVID-19 vaccination in Spain is the national vaccination strategy started on 27 December 2020 in order to vaccinate the country's population against COVID-19 within the international effort to fight the COVID-19 pandemic.
As of 23 November 2021, the following doses had been received: 59,296,575 Pfizer–BioNTech COVID-19 vaccine doses, 16,105,300 Moderna vaccine doses, 17,427,500 Oxford–AstraZeneca vaccine doses and 2,659,000 Janssen vaccine doses, totaling to 95,488,375 doses. Out of these doses, 75,173,640 had been administered.
The autonomous communities with the highest fully-vaccinated percentage are Asturias (85.1%) and Galicia (84.9%), while the communities with the lowest percentage are the Canary Islands (75.7%) and the Balearic Islands (72.4%). The Spanish average percentage was 79.1%, amounting to 37,557,243 people.
Out of the total, 3,776,118 have been administered as additional doses, or third doses, of which 3,319,229 are Pfizer–BioNTech COVID-19 vaccine doses and 456,889 are Moderna vaccine doses.
The amount of doses ordered from Q1 to Q4 of 2021 is 141,943,261.
There are several COVID-19 vaccines at various stages of development around the world.
| Vaccine | Doses ordered | Approval | Deployment | Age Applied[2] |
|---|---|---|---|---|
| Pfizer–BioNTech | 146 million | 12+ | ||
| Moderna | 52 million | 12+ | ||
| Oxford-AstraZeneca | 31 million | 60–69 | ||
| Janssen | 20 million | 40+ | ||
| Novavax | 2,2 million | Pending | Pending | |
| Valneva | Pending | Pending | Pending | Pending |
| Sanofi–GSK | Pending | Pending | Pending | Pending |
| CureVac | No |
Phases and development of the vaccination campaign
Public opinion
Centre for Sociological Research
According to the Centre for Sociological Research, the Spanish public organism in charge of investigating the public opinion of the society on many different topics, these are the data of the acceptance of the vaccine among the Spanish population:
| Oct 2020 | Nov 2020 | Dec 2020 | Jan 2021 | Feb 2021 | Mar 2021 | Apr 2021 | May 2021 | Jun 2021 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| YES | Yes | 40,2% | 36,8% | 40,5% | 72,5% | 82,9% | 82,5% | 70,4% | 53,2% | 37,8% |
| They are already vaccinated | – | – | – | – | – | 5,1% | 15,0% | 37,7% | 55,1% | |
| Yes, depending on the origin of the vaccine | 0,2% | 0,1% | 0,6% | 0,2% | 0,4% | 0,6% | 2,4% | 1,2% | 0,4% | |
| Yes, if there are guarantees, if it is proven, if it is reliable | 2,2% | 1,4% | 16,2% | 2,5% | 1,8% | 0,9% | 1,6% | 0,5% | 0,2% | |
| Yes, on the advice of the authorities, scientists or health professionals | 0,2% | 0,3% | 3,6% | 1,3% | 0,9% | 0,3% | 0,4% | 0,3% | 0,1% | |
| Yes, if there is enough information | 0,2% | 0,0% | 3,2% | 0,8% | 0,4% | 0,2% | 0,3% | 0,2% | 0,1% | |
| TOTAL YES | 43,0% | 38,6% | 64,1% | 77,3% | 86,4% | 89,6% | 90,1% | 93,1% | 93,7% | |
| NO | No | 43,8% | 47,0% | 28,0% | 16,5% | 6,5% | 5,4% | 5,3% | 3,7% | 3,6% |
| TOTAL NO | 43,8% | 47,0% | 28,0% | 16,5% | 6,5% | 5,4% | 5,3% | 3,7% | 3,6% | |
| NK
+ NA |
Does not know, doubts | 12,4% | 13,4% | 5,3% | 4,5% | 5,5% | 3,8% | 3,3% | 2,4% | 1,8% |
| Other answers | 0,6% | 0,7% | 2,5% | 1,7% | 1,6% | 1,0% | 1,3% | 0,7% | 0,6% | |
| N.A. (Not answers) | 0,4% | 0,3% | 0,1% | 0,1% | 0,1% | 0,0% | 0,1% | 0,0% | 0,1% | |
| TOTAL NK/NA (OTHER ANSWERS) | 13,4% | 14,4% | 7,9% | 6,3% | 7,2% | 4,8% | 4,7% | 3,1% | 2,5% | |
| Sample | 2.924 | 3.853 | 3.817 | 3.852 | 3.869 | 3.820 | 3.823 | 3.814 | 3.814 | |
| Reference | [5] | [6] | [7] | [8] | [9] | [10] | [11] | [12] | [13] | |
From February 2021 onwards, the centre began to ask among those who did not want to take the vaccine about the reasons they had for choosing not to receive the shot, obtaining the following results:
| February 2021 | March 2021 | April 2021 | May 2021 | June 2021 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| % question | % total sample | % question | % total sample | % question | % total sample | % question | % total sample | % question | % total sample | |
| They do not rely on these vaccines | 31,2% | 2,0280% | 29,3% | 1,5822% | 34,6% | 1,8338% | 25,3% | 0,9361% | 35,4% | 1,2744% |
| Because of fear to develop risks for their health/side-collateral effects | 18,5% | 1,2025% | 20,1% | 1,0854% | 25,3% | 1,3409% | 25,3% | 0,9361% | 15,6% | 0,5616% |
| They are against all vaccines in general | 4,3% | 0,2795% | 1,7% | 0,0981% | 3,1% | 0,1643% | 4,4% | 0,1628% | 7,1% | 0,2556% |
| They prefer to wait to see how they work | 9,2% | 0,5980% | 6,0% | 0,3240% | 3,5% | 0,1855% | 7,7% | 0,2849% | 6,9% | 0,2484% |
| They do not believe they are effective | 8,3% | 0,5395% | 7,1% | 0,3834% | 5,2% | 0,2756% | 8,7% | 0,3219% | 5,2% | 0,1872% |
| They do not consider it necessary (without specifying) | – | – | 4,6% | 0,2484% | 3,7% | 0,1961% | 7,3% | 0,2701% | 4,7% | 0,1692% |
| Because of lack of guarantees: few trials, earliness, lack of analysis | 4,6% | 0,2990% | 4,6% | 0,2484% | 3,7% | 0,1961% | 4,2% | 0,1554% | 3,1% | 0,1116% |
| COVID-19 denial | – | – | 3,1% | 0,1674% | 2,8% | 0,1484% | 0,7% | 0,0259% | 3,1% | 0,1116% |
| Because of having few possibilities of infection | 3,2% | 0,2080% | 3,5% | 0,1890% | 1,0% | 0,0530% | 4,8% | 0,1776% | 3,0% | 0,1080% |
| Because of having allergies, other diseases or treatments, breastfeeding, pregnancy | 3,0% | 0,1950% | 2,1% | 0,1134% | 3,6% | 0,1908% | 3,7% | 0,1369% | 2,3% | 0,0828% |
| Because of having passed COVID-19 | – | – | 4,6% | 0,2484% | 3,4% | 0,1802% | 0,2% | 0,0074% | 2,2% | 0,0792% |
| Because of lack of information | 1,5% | 0,0975% | 3,7% | 0,1998% | 1,1% | 0,0583% | 0,7% | 0,0259% | 1,4% | 0,0504% |
| There are other people more vulnerable or with a higher risk than them | 0,8% | 0,052% | 1,0% | 0,0540% | – | – | – | – | 0,8% | 0,0288% |
| They do not ever get vaccinated | 1,0% | 0,0650% | 1,5% | 0,0810% | 1,6% | 0,0848% | 1,5% | 0,0555% | - | - |
| Because of any other reason | 12,9% | 0,8385% | 4,9% | 0,2646% | 5,8% | 0,3074% | 3,1% | 0,1147% | 7,3% | 0,2628% |
| They do not know, doubt | 1,3% | 0,0845% | 1,9% | 0,1026% | 1,0% | 0,0530% | 1,8% | 0,0666% | - | - |
| N.A. (Not answers) | 0,2% | 0,0130% | – | – | 0,5% | 0,0265% | 0,8% | 0,0296% | 1,9% | 0,0684% |
| Sample | 251 | 3.869 | 208 | 3.820 | 203 | 3.823 | 143 | 3.814 | 138 | 3.814 |
| Reference | [9] | [10] | [11] | [12] | [13] | |||||
Vaccinated Spanish public figures
The progress of the vaccination campaign to more and more demographic groups has allowed many public figures to receive one or two doses of the vaccine correspondent to them by age or belonging to some other priority group.
Politicians
State authorities
- King Philip VI of Spain received the vaccine on May 29, 2021, at 53 years old. The head of State received the vaccine without medical transcendence, and was only informed after receiving the jab. He was vaccinated once the access for his age group was opened, at the massive vaccination point set up in WiZink Center in Madrid, as any other citizen. He was accompanied by the head of the Royal Family medical service, Juan Martínez, and by the Vice-councillor for Public Health and COVID-19 Plan of the Community of Madrid, Antonio Zapatero. Regarding the vaccine brand, although it was not officially communicated, it is known that only Janssen vaccines were given that day. With respect to the published images, these were not distributed by the Royal Family, however, the TV programme Cuatro al día from the Spanish broadcasting station Cuatro published a picture of the head of State receiving the vaccine.